Werner Dittrich

Title: Werner Dittrich: Innovator in Biomedical Research

Introduction

Werner Dittrich is a notable inventor based in Frankfurt-am-Main, Germany. He has made significant contributions to the field of biomedical research, particularly in the development of innovative therapeutic solutions. With a total of 2 patents, Dittrich's work focuses on addressing critical health issues.

Latest Patents

One of his latest patents involves polypeptide variants of human fibroblast growth factor 21 (FGF21) and fusion molecules thereof. This invention relates to their use as medicaments for treating obesity, metabolic syndrome, diabetes mellitus, and other related conditions. Another significant patent discloses mammalian cell lines that express functional nematode acetylcholine receptors. These cell lines are essential for high-throughput screening assays to identify new parasiticidal compounds.

Career Highlights

Throughout his career, Dittrich has worked with prominent companies such as Sanofi and Boehringer Ingelheim Animal Health, Inc. His experience in these organizations has allowed him to contribute to various innovative projects and advancements in the biomedical field.

Collaborations

Dittrich has collaborated with notable professionals in his field, including Lance Hammerland and Brenda Bondesen. These partnerships have further enhanced his research and development efforts.

Conclusion

Werner Dittrich is a distinguished inventor whose work in biomedical research has the potential to impact the treatment of various health conditions. His innovative patents and collaborations reflect his commitment to advancing medical science.